Browsing by Contributors Cui, Y

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
 
Showing results 1 to 5 of 5
PreviewIssue DateTitleContributor(s)
2016 PC Volume 37 Issue 1 January (19).pdf.jpg2016Assessments of Coronary Artery Visibility and Radiation Dose in Infants with Congenital Heart Disease on Cardiac 128-slice CT and on Cardiac 64-slice CTCui, Y; Zheng, M Huang J; Liu, J Li H
2017 IEoJ Volume 46 Issue 6 December (32).pdf.jpg2017Cohort Profile: The Atlantic Partnership for Tomorrow’s Health (Atlantic PATH) StudySweeney, E; Cui, Y; DeClercq, V; Devichand, P; Forbes, C; Grandy, S; Hicks, J M T; Keats, M; Parker, L; Thompson, D; Volodarsky, M; Yu, Z M; Dummer, T J B
2017 JCCPsychology Volume 85 Issue 10 October (4).pdf.jpg2017Multiple variants in 5q31 . 1 are associated with systemic lupus erythematosus susceptibility and subphenotypes in the Han Chinese populationWen, L L; Zhu, Z W; Yang, C; Liu, L; Zuo, X B; Morris, D L; Dou, J F; Ye, L; Cheng, Y Y; Guo, H M; Huang, H Q; Lin, Y; Zhu, C H; Tang, L L; Chen, M Y; Zhou, Y; Ding, Y T; Zhou, F S; Gao, J P; Tang, X F; Zheng, X D; Wang, W J; Yin, X Y; Tang, H Y; Sun, L D; Yang, S; Zhang, X J; Sheng, Y J; Cui, Y
2008OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivationCui, Y; Ying, Y; Van Hasselt, A; Ng, KM; Yu, J; Zhang, Q; Jin, J; Liu, D; Rhim, JS; Rha, SY; Loyo, M; Chan, ATC; Srivastava, G; Tsao, GSW; Sellar, GC; Sung, JJY; Sidransky, D; Tao, Q
2007The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomasSrivastava, G; Tsao, GSW; Chan, SL; Cui, Y; Van Hasselt, A; Li, H; Jin, H; Ng, KM; Wang, Y; Lee, KY; Zhong, S; Robertson, KD; Rha, SY; Chan, ATC; Tao, Q